Butterly, E, Wei, L, Adler, A I, Almazam, S A, Alsallumi, K, Blackbourn, L, Dias, S, Peter, H, Hughes, K A, Lewsey, J, Lindsay, R S, McGurnaghan, S, Petrie, J R, Phillippo, D, Sattar, N A, Tomlinson, L, Welton, N J, Wild, S H & McAllister, D A 2022, ' Calibrating a network meta-analysis of diabetes trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population : a systematic review protocol ', BMJ Open, vol. 12, no. 10, 066491, pp. e066491 . https://doi.org/10.1136/bmjopen-2022-066491
Adler, A, Slayen, S, Stegenga, H, Guo, Y, Diaz, R, Welton, N J, Westwood, N, Doull, I & Crawley, C 2022, ' NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma ', Lancet Respiratory Medicine, vol. 10, no. 10, pp. e92-e93 . https://doi.org/10.1016/S2213-2600(22)00301-0
Nazarzadeh, M, Bidel, Z, Canoy, D, Copland, E, Bennett, D A, Dehghan, A, Davey Smith, G, Holman, R R, Woodward, M, Gupta, A, Adler, A I, Wamil, M, Sattar, N, Cushman, W C, McManus, R J, Koon, T, Davis, B R, Chalmers, J, Pepine, C J & Rahimi, K 2022, ' Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes : an individual participant-level data meta-analysis ', Lancet Diabetes and Endocrinology, vol. 10, no. 9, pp. 645-654 . https://doi.org/10.1016/S2213-8587(22)00172-3